Ionis Pharmaceuticals Balance Sheet
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ionis Pharmaceuticals financial position
At the end of fiscal 2025, Ionis Pharmaceuticals reported total assets of $3.52 billion, up 17.3% from a year earlier against total liabilities of $3.03 billion. Shareholders' equity stood at $489.1 million, or 13.9% of assets. The company held $372.3 million in cash and equivalents against $1.76 billion of debt, a net debt position of $1.39 billion.
The current ratio (current assets divided by current liabilities) was 3.83, meaning short-term assets cover obligations due within a year. Debt-to-equity was 3.60.
Summary generated from market data by MetaCap's automated system. Methodology
Ionis Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 372.26M | 242.08M | 399.27M | 276.47M | 869.19M | 397.66M | 683.29M | 278.82M | 129.63M | 84.69M |
| Short-Term Investments | 2.31B | 2.06B | 1.93B | 1.71B | 1.25B | 1.49B | 1.82B | 1.81B | 893.09M | 580.54M |
| Inventory | 10.05M | 12.51M | 7.44M | 22.03M | 24.81M | 21.96M | 18.18M | 8.58M | 9.98M | — |
| Total Current Assets | 2.99B | 2.62B | 2.64B | 2.20B | 2.35B | 2.13B | 2.72B | 2.21B | 1.17B | 797.93M |
| Property, Plant & Equipment | 123.05M | 94.25M | 71.04M | 74.29M | 178.07M | 181.08M | 153.65M | 132.16M | 121.91M | 92.84M |
| Intangible Assets | — | — | — | — | 29.00M | 27.94M | 25.67M | 24.03M | 22.00M | 20.36M |
| Long-Term Investments | 773.71M | 652.54M | 653.49M | 509.82M | 635.12M | — | — | — | — | — |
| Total Assets | 3.52B | 3.00B | 2.99B | 2.53B | 2.61B | 2.39B | 3.23B | 2.67B | 1.32B | 912.47M |
| Accounts Payable | 28.08M | 42.96M | 26.03M | 17.92M | 11.90M | 17.20M | 16.07M | 28.66M | 24.89M | 21.12M |
| Short-Term Debt | 432.12M | 165.00K | 157.00K | 151.00K | — | 300.46M | 2.03M | 13.75M | 1.62M | 1.19M |
| Total Current Liabilities | 781.57M | 309.32M | 448.09M | 311.56M | 240.55M | 598.90M | 273.00M | 280.29M | 243.61M | 133.78M |
| Long-Term Debt | 1.33B | 1.20B | 1.24B | 1.18B | — | 539.11M | 785.50M | — | — | — |
| Total Liabilities | 3.03B | 2.42B | 2.60B | 1.96B | 1.84B | 1.65B | 1.55B | 1.48B | 957.49M | 812.90M |
| Shareholders' Equity | 489.09M | 588.35M | 386.69M | 572.89M | 771.74M | 743.28M | 1.47B | 1.05B | 281.01M | 99.56M |
| Retained Earnings | -2.63B | -2.25B | -1.80B | -1.43B | -1.16B | -1.13B | -707.53M | -967.29M | -1.24B | -1.18B |
| Total Debt | 1.76B | 1.20B | 1.24B | 1.18B | — | 839.57M | 787.53M | 13.75M | 1.62M | 1.19M |
| Net Cash (Debt) | 917.32M | 1.10B | 1.09B | 810.99M | 2.11B | 1.05B | 1.71B | 2.07B | 1.02B | 664.04M |
| Shares Outstanding | 163.30M | 157.91M | 144.34M | 142.06M | 141.21M | 140.37M | 140.34M | 137.93M | 124.98M | 121.64M |
This table shows 10 annual periods of Ionis Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow IONS's reporting calendar. What is a balance sheet?